EMA Authorised: Elmiron (pentosan polysulfate sodium) — bene-Arzneimittel GmbH

View source ↗

Summary

The EMA has authorised Elmiron (pentosan polysulfate sodium) for interstitial cystitis, with bene-Arzneimittel GmbH as the marketing authorization holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis

Drugs mentioned

• Elmiron (pentosan polysulfate sodium)

Snippet

Status: Authorised. Therapeutic area: Cystitis, Interstitial. MAH: bene-Arzneimittel GmbH. Decision date: 31/07/2026